Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

The phase (trans)formation and physical state of a model drug in mesoscopic confinement.

Ukmar T, Godec A, Planinšek O, Kaučič V, Mali G, Gaberšček M.

Phys Chem Chem Phys. 2011 Sep 21;13(35):16046-54. doi: 10.1039/c1cp20874h. Epub 2011 Aug 8.

PMID:
21826312
2.

Phase characterization of indomethacin in adsorbates onto hydroxyethylcellulose.

Bogdanova S, Bontcheva E, Avramova N.

Drug Dev Ind Pharm. 2007 Aug;33(8):900-6.

PMID:
17729108
3.

Studies on in vitro release behaviour of indomethacin-loaded polystyrene microparticles.

Tamilvanan S, Sa B.

Int J Pharm. 2000 May 25;201(2):187-97.

PMID:
10878325
4.

Mechanistic evaluation of the effect of thermal-treating on Eudragit RS matrices.

Azarmi S, Ghaffari F, Löbenberg R, Nokhodchi A.

Farmaco. 2005 Nov-Dec;60(11-12):925-30. Epub 2005 Oct 11.

PMID:
16223498
5.
6.

Manipulating crystal growth and polymorphism by confinement in nanoscale crystallization chambers.

Hamilton BD, Ha JM, Hillmyer MA, Ward MD.

Acc Chem Res. 2012 Mar 20;45(3):414-23. doi: 10.1021/ar200147v. Epub 2011 Oct 28.

PMID:
22035061
7.

Microporous membrane drug delivery system for indomethacin.

Elchidana PA, Deshpande SG.

J Control Release. 1999 Jun 2;59(3):279-85.

PMID:
10332060
8.
10.
11.

Drug delivery properties of macroporous polystyrene solid foams.

Canal C, Aparicio RM, Vilchez A, Esquena J, García-Celma MJ.

J Pharm Pharm Sci. 2012;15(1):197-207.

12.

Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery.

Heikkilä T, Salonen J, Tuura J, Kumar N, Salmi T, Murzin DY, Hamdy MS, Mul G, Laitinen L, Kaukonen AM, Hirvonen J, Lehto VP.

Drug Deliv. 2007 Aug;14(6):337-47.

PMID:
17701523
13.

Influence of phase transformation on indomethacin release from microemulsions.

Trotta M.

J Control Release. 1999 Aug 5;60(2-3):399-405.

PMID:
10425344
14.

Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug.

Hu Y, Wang J, Zhi Z, Jiang T, Wang S.

J Colloid Interface Sci. 2011 Nov 1;363(1):410-7. doi: 10.1016/j.jcis.2011.07.022. Epub 2011 Jul 21.

PMID:
21820127
15.

Time-controlled pulse-drug release from dry-coated wax matrix tablets for colon drug delivery.

Peerapattana J, Otsuka K, Otsuka M.

Biomed Mater Eng. 2004;14(3):293-301.

PMID:
15299241
16.

Using the low-frequency Raman spectroscopy to analyze the crystallization of amorphous indomethacin.

Hédoux A, Paccou L, Guinet Y, Willart JF, Descamps M.

Eur J Pharm Sci. 2009 Sep 10;38(2):156-64. doi: 10.1016/j.ejps.2009.06.007. Epub 2009 Jul 8.

PMID:
19591926
17.

Biocompatibility and drug release behavior of spontaneously formed phospholipid polymer hydrogels.

Kimura M, Takai M, Ishihara K.

J Biomed Mater Res A. 2007 Jan;80(1):45-54.

PMID:
16958047
18.

The in vitro and in vivo indomethacin release from self-setting bioactive glass bone cement.

Otsuka M, Nakahigashi Y, Matsuda Y, Kokubo T, Yoshihara S, Fujita H, Nakamura T.

Biomed Mater Eng. 1997;7(5):291-302.

PMID:
9457380
19.

Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.

Akhgari A, Afrasiabi Garekani H, Sadeghi F, Azimaie M.

Int J Pharm. 2005 Nov 23;305(1-2):22-30. Epub 2005 Oct 19.

PMID:
16236475
20.

Enzymatic desorption of layer-by-layer assembled multilayer films and effects on the release of encapsulated indomethacin microcrystals.

Wang C, Ye S, Dai L, Liu X, Tong Z.

Carbohydr Res. 2007 Nov 5;342(15):2237-43. Epub 2007 Jun 30.

PMID:
17662265

Supplemental Content

Support Center